These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3886953)

  • 1. [Clinical application of bredinin].
    Aso Y; Tajima A
    Nihon Rinsho; 1985 Jan; 43(1):136-40. PubMed ID: 3886953
    [No Abstract]   [Full Text] [Related]  

  • 2. Bredinin treatment in clinical kidney allografting.
    Tajima A; Hata M; Ohta N; Ohtawara Y; Suzuki K; Aso Y
    Transplantation; 1984 Aug; 38(2):116-8. PubMed ID: 6380037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
    Zaoui P; Serre-Debeauvais F; Bayle F; Bessard G; Pintar P; Deteix P; Janbon B; Vialtel P
    Transplant Proc; 1995 Feb; 27(1):1064-5. PubMed ID: 7878806
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
    Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
    Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with the use of mizoribine in human renal transplantation.
    Dohi K; Yahata H; Fukuda Y; Takenaka M; Tabe Y; Ono E; Fukuda M; Omotehara T; Eto T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):809-12. PubMed ID: 6398817
    [No Abstract]   [Full Text] [Related]  

  • 6. Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
    Lee HA; Slapak M; Raman GV; Mason JC; Digard N; Wise M
    Transplant Proc; 1995 Feb; 27(1):1050-1. PubMed ID: 7878799
    [No Abstract]   [Full Text] [Related]  

  • 7. Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
    Lee HA; Slapak M; Venkatraman G; Mason J; Digard N; Wise M
    Transplant Proc; 1993 Aug; 25(4):2699-700. PubMed ID: 8356720
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from cyclosporine to bredinin in canine orthotopic liver transplantation.
    Uchida H; Yokota K; Sato K; Masaki Y; Osakabe T; Nakayama Y; Takishima T; Aso K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1290-4. PubMed ID: 3547860
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
    Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
    Amemiya H; Suzuki S; Hayashi R; Nakatani T
    Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
    Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
    Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
    Ishibashi M; Jiang S; Kokado Y; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1854-8. PubMed ID: 2469228
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
    Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
    [No Abstract]   [Full Text] [Related]  

  • 14. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
    Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
    Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of a new drug, bredinin, on canine kidney allotransplant survival.
    Uchida H; Yokota K; Akiyama N; Masaki Y; Aso K; Okubo M; Okudaira M; Kato M; Kashiwagi N
    Transplant Proc; 1979 Mar; 11(1):865-70. PubMed ID: 377720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
    Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of Bredinin in renal transplantation.
    Inou T; Kusaba R; Takahashi I; Sugimoto H; Kuzuhara K; Yamada Y; Yamauchi J; Otsubo O
    Transplant Proc; 1980 Sep; 12(3):526-8. PubMed ID: 7013183
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
    Takeuchi N; Ohshima S; Matsuura O; Ono Y; Katoh N; Yamada S; Fujita T; Kinukawa T; Hirabayashi S; Sahashi M
    Transplant Proc; 1994 Aug; 26(4):1907-9. PubMed ID: 8066621
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of bredinin in renal transplant patients.
    Takada K; Asada S; Ichikawa Y; Sonoda T; Takahara S; Nagano S; Fukunishi T
    Eur J Clin Pharmacol; 1983; 24(4):457-61. PubMed ID: 6345179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of bredinin in renal transplantation.
    Inou T; Kusaba R; Takahashi I; Sugimoto H; Kuzuhara K; Yamada Y; Yamauchi J; Otsubo O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):315-8. PubMed ID: 7022843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.